Legally Protecting Inventions and Innovations Related to the Medical Field
Laxxon Medical to Attend 42nd Annual J.P. Morgan Healthcare Conference in San Francisco
3D Screen Printing is Transforming Drug Manufacturing and Improving Patient Experiences
What is First Pass Metabolism?
Laxxon Medical joins German Accelerator’s Southeast Asia Market Access Class of 2023
Laxxon Medical to Attend BIO-Europe Munich 2023
Medication Errors Are On The Rise
Patient-Specific Drug Formulations Through 3D Screen Printing
Why Are Generic Pharmaceutical Drugs Important?
Multi-Drug Combinations for Personalized Medicine with 3D Screen Printing
Enhancing Drug Adherence Through 3D Printing
3D Printing for Complex Drug Delivery Systems
Improving Drug Solubility and Bioavailability Through 3D Printing
Laxxon Medical and CU Innovations at Anschutz Medical Campus Announce Strategic Partnership
3D Screen Printing Technology Enables Fabrication of Oral Drug Dosage Forms
Laxxon Medical to Participate in 2023 BIO International Convention
Laxxon Medical Announces Formation of Scientific Advisory Board with Renowned Pharmaceutical Experts
10 Strategies for Improving Patient Experience
Laxxon Medical's Commitment to Meeting and Exceeding CGMP Regulations In 3D Printed Pharmaceuticals
Interview with Laxxon COO Klaus Kuehne